| A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial R Nachbagauer, J Feser, A Naficy, DI Bernstein, J Guptill, EB Walter, ... Nature medicine 27 (1), 106-114, 2021 | 247 | 2021 |
| Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial DI Bernstein, J Guptill, A Naficy, R Nachbagauer, F Berlanda-Scorza, ... The lancet infectious diseases 20 (1), 80-91, 2020 | 129 | 2020 |
| Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate W Sun, SR Leist, S McCroskery, Y Liu, S Slamanig, J Oliva, F Amanat, ... EBioMedicine 62, 2020 | 101 | 2020 |
| Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model ME Ermler, E Kirkpatrick, W Sun, R Hai, F Amanat, V Chromikova, ... Journal of virology 91 (12), 10.1128/jvi. 00286-17, 2017 | 91 | 2017 |
| A Newcastle disease virus (NDV) expressing a membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine W Sun, S McCroskery, WC Liu, SR Leist, Y Liu, RA Albrecht, S Slamanig, ... Vaccines 8 (4), 771, 2020 | 81 | 2020 |
| Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance STH Liu, MA Behzadi, W Sun, AW Freyn, WC Liu, F Broecker, RA Albrecht, ... The Journal of clinical investigation 128 (11), 4992-4996, 2018 | 69 | 2018 |
| Development of influenza B universal vaccine candidates using the “mosaic” hemagglutinin approach W Sun, E Kirkpatrick, M Ermler, R Nachbagauer, F Broecker, F Krammer, ... Journal of virology 93 (12), 10.1128/jvi. 00333-19, 2019 | 64 | 2019 |
| A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses W Sun, Y Liu, F Amanat, I González-Domínguez, S McCroskery, ... Nature communications 12 (1), 6197, 2021 | 61 | 2021 |
| A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains F Broecker, STH Liu, N Suntronwong, W Sun, MJ Bailey, R Nachbagauer, ... npj Vaccines 4 (1), 31, 2019 | 49 | 2019 |
| Safety and immunogenicity of a newcastle disease virus vector-based SARS-CoV-2 vaccine candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs JH Lara-Puente, JM Carreño, W Sun, A Suárez-Martínez, ... MBio 12 (5), 10.1128/mbio. 01908-21, 2021 | 36 | 2021 |
| Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase … P Pitisuttithum, V Luvira, S Lawpoolsri, S Muangnoicharoen, ... EClinicalMedicine 45, 2022 | 35 | 2022 |
| Immunodominance of antigenic site B in the hemagglutinin of the current H3N2 influenza virus in humans and mice F Broecker, STH Liu, W Sun, F Krammer, V Simon, P Palese Journal of Virology 92 (20), 10.1128/jvi. 01100-18, 2018 | 32 | 2018 |
| Matrix proteins of Nipah and Hendra viruses interact with beta subunits of AP-3 complexes W Sun, TS McCrory, WY Khaw, S Petzing, T Myers, AP Schmitt Journal of virology 88 (22), 13099-13110, 2014 | 32 | 2014 |
| Extending the stalk enhances immunogenicity of the influenza virus neuraminidase F Broecker, A Zheng, N Suntronwong, W Sun, MJ Bailey, F Krammer, ... Journal of Virology 93 (18), 10.1128/jvi. 00840-19, 2019 | 28 | 2019 |
| An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations M Rajendran, W Sun, P Comella, R Nachbagauer, TJ Wohlbold, ... PloS one 13 (4), e0194830, 2018 | 26 | 2018 |
| Antibody responses toward the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets, and humans W Sun, DS Kang, A Zheng, STH Liu, F Broecker, V Simon, F Krammer, ... Journal of Virology 93 (2), 10.1128/jvi. 01673-18, 2019 | 24 | 2019 |
| The influenza B virus hemagglutinin head domain is less tolerant to transposon mutagenesis than that of the influenza A virus BO Fulton, W Sun, NS Heaton, P Palese Journal of virology 92 (16), 10.1128/jvi. 00754-18, 2018 | 24 | 2018 |
| Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1 … AD Dang, TD Vu, HH Vu, AT Van Pham, MTN Dang, B Van Le, TH Duong, ... Vaccine 40 (26), 3621-3632, 2022 | 22 | 2022 |
| Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts R Nachbagauer, B Salaun, D Stadlbauer, MA Behzadi, D Friel, ... NPJ vaccines 4 (1), 51, 2019 | 22 | 2019 |
| Mutations in the transmembrane domain and cytoplasmic tail of Hendra virus fusion protein disrupt virus-like-particle assembly N Cifuentes-Muñoz, W Sun, G Ray, PT Schmitt, S Webb, K Gibson, ... Journal of virology 91 (14), 10.1128/jvi. 00152-17, 2017 | 22 | 2017 |
